Ravindra Kumar Saran

Dr. Ravindra Kumar Saran


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Surgical Neurology International
Verified
Journal Article
Open access
CGCharandeepS Gandhoke
CharandeepS Gandhoke
ADAditi Dewan
Aditi Dewan
DGDivya Gupta
Divya Gupta
SSSimranK Syal
SimranK Syal
AJAnita Jagetia
Anita Jagetia
DSDaljit Singh
Daljit Singh
Olfactory neuroblastoma (ONB) is a rare malignant neuroectodermal tumor of the nasal cavity. Mixed olfactory neuroblastoma which contains areas of divergent differentiation is even rare. Till date, only 4 cases of mixed olfactory neuroblastomas have been reported. We report the case of a 46-year-old male who presented with the chief complaints of nasal bleeding and nasal obstruction since 4 months. Radiological imaging was suggestive of a large heterogeneous mass in the left superior nasal cavity with extensions into bilateral maxillary, ethmoidal, and sphenoidal sinuses, as well as into the anterior cranial fossa. Bifrontal osteoplastic craniotomy and excision of the intracranial part of the tumor from above and transnasal endoscopic removal of the mass in the nasal cavities and paranasal sinuses from below was done. Postoperative radiological imaging was suggestive of gross complete excision of the mass. Histopathological diagnosis was "mixed olfactory neuroblastoma-carcinoma (squamous and glandular differentiation) Hyams grade IV." On immunohistochemistry, the tumor cells were positive for neuron specific enolase (NSE), synaptophysin, chromogranin, and CD56 and peripherally for S100. Because of personal reasons, the patient did not take adjuvant radiotherapy. He presented again after 2 months with a full blown recurrence of esthesioneuroblastoma with similar extensions as before. The patient is now planned for salvage surgery followed by adjuvant chemoradiation. We report the 5th case in the world of mixed olfactory neuroblastoma-carcinoma with squamous and glandular differentiation. From an analysis of the findings in the 5 reported cases of mixed olfactory neuroblastomas, one might infer that a separate subcategory of ONB, i.e., mixed ONB, should be considered because mixed ONBs have an aggressive behavior, high rates of recurrence, and these tumors should be treated aggressively by multimodality treatment.

25 May 2005 in Cytopathology
Verified
Journal Article
Closed access
PDF file
PKP. Kumar
P. Kumar
RSRavindra Kumar Saran
Ravindra Kumar Saran
RGR. Gondal
R. Gondal
VMV. Malhotra
V. Malhotra

13 March 2017 in Neuropathology
Verified
Journal Article
Closed access
PDF file
RGRakesh Kumar Gupta
Rakesh Kumar Gupta
RSRavindra Kumar Saran
Ravindra Kumar Saran
ASArvind K. Srivastava
Arvind K. Srivastava
AJAnita Jagetia
Anita Jagetia
LGLalit Garg
Lalit Garg
MSMehar C. Sharma
Mehar C. Sharma

1 April 2016 in Journal of Neurosciences in Rural Practice
Verified
Journal Article
Open access
PDF file
RGRakesh Kumar Gupta
Rakesh Kumar Gupta
RSRavindra Kumar Saran
Ravindra Kumar Saran
AJAnita Jagetia
Anita Jagetia
PNPoonam Narang
Poonam Narang

1 January 2018 in Journal of Cytology
Verified
Journal Article
Open access
PDF file
RSRavindra Kumar Saran
Ravindra Kumar Saran
RGRakesh Kumar Gupta
Rakesh Kumar Gupta
KMKaushik Majumdar
Kaushik Majumdar
SSSiddharth Srivastava
Siddharth Srivastava
PSPuja Sakhuja
Puja Sakhuja
VBVineeta V Batra
Vineeta V Batra
Objective: Endoscopic ultrasound-guided fine-needle aspiration cytology (EUS-FNAC) is a precise and safe technique that provides both radiological and pathological diagnosis with a better diagnostic yield and minimal adverse events. EUS-FNAC led to the remarkable increase in the detection rate of incidentaloma found during radiologic staging or follow-up in various malignancy or unrelated conditions. Aims: We did this preliminary study with an aim to evaluate the role of EUS-FNA in diagnosing and classifying adrenal lesions, clinical impact, and compare the outcome with the previously published literature. Materials and Methods: We included 32 consecutive cases (both retrospective and prospective) of EUS-guided adrenal aspirate performed over a period of 3.3 years. The indications for the aspirate in decreasing order were metastasis (most common carcinoma gall bladder) > primary adrenal mass > disseminated tuberculosis > pyrexia of unknown origin. On EUS, 28 cases revealed space occupying lesion or mass (two cases bilateral) and four cases revealed diffuse enlargement (two cases bilateral) with a mean size of 21 mm. Results: The cytology reports were benign adrenal aspirate (43.8%), metastatic adenocarcinoma (15.6%), histoplasmosis (9.4%), tuberculosis (9.4%), round cell tumor (6.2%), adrenocortical carcinoma (3.1%), and descriptive (3.1%). Three cases (9.4%) yielded inadequate sample. The TNM staging was altered in 22.23% of the cases by result of adrenal aspirate. Conclusions: EUS-FNA of the adrenal gland is a safe, quick, and sensitive and real-time diagnostic technique, which requires an integrated approach of clinician, endoscopist, and cytopathologist for high precision in diagnosis. Although the role of EUS-FNA for right adrenal is not much described, we found adequate sample yield in all the four patients that underwent the procedure.

27 September 2022 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
DCDimple Chaudhary
Dimple Chaudhary
PBPriyanka Banga
Priyanka Banga
PSPuja Sakhuja
Puja Sakhuja
SGSurbhi Goyal
Surbhi Goyal
RSRavindra Kumar Saran
Ravindra Kumar Saran
AAAnil K. Agarwal
Anil K. Agarwal